Effectivity of heparin in assisted reproduction

European Journal of Medical Research

Volumn 9, Issue 4, 2004, Pages 207-214

  Fiedler, Klaus ^a   Würfel, Wolfgang ^a  

^a Kinderwunsch Centrum München KCM Fertility Center Munich   (Germany)

Author keywords

Assisted reproduction; Heparin; IVF; RIF(repeated implantation failure)

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN;

ANTIPHOSPHOLIPID SYNDROME; FEMALE; FERTILIZATION IN VITRO; HUMAN; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; RECURRENT ABORTION; REVIEW;

ABORTION, HABITUAL; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; FEMALE; FERTILIZATION IN VITRO; HEPARIN; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME;

EID: 3242731459     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (76)

1. Armant DR, Wang J, Liu Z (2000) Intracellular signaling in the developing blastocyst as a consequence of the maternal-embryonic dialogue. Semin Reprod Med 18: 273-287
2. Bahar AM, Kwak JY, Beer AE, et al. (1993) Antibodies to phospholipids and nuclear antigens in non-pregnant women with unexplained spontaneous recurrent abortions. J Reprod Immunol 24: 213-222
3. 2-glycoprotein-1 antibodies in anti-cardiolipin and lupus anticoagulant seronegative patients. Human Reprod Immunol 14: 1956-1959
4. Branch DW (1987) Immunologic disease and fetal death. Clin Obstet Gynecol 30: 295-311
5. Carreras LO, Forastiero RR, Martinuzzo ME (2000) Which are the best biological markers of the anti-phospholipid syndrome? J Autoimmun 15: 163-172
6. Chilcott IT, Margara R, Cohen H, Rai R, Skull J, Pickering W, Regan L (2000) Pregnancy outcome is not affected by antiphospholipid antibody status in women referred for in vitro fertilization. Fertil Steril 73: 526-530
7. Clark DA, Coulam CB, Daya S, et al. (2001) unexplained sporadic and recurrent miscarrage in the new millennium: a critical analysis of immune mechanisms and treatments. Human Reproduction Update 7(5): 501-511
8. Clark DA (2003) Is there any evidence for immunologically mediated or immunologically modifiable early pregnancy failure? J Ass Reprod Genetics 20: 63-72
9. Coulam C. Kaider B. Janowicz P. Roussev R (1997) Antiphospholipid antibodies associated with implantation failure after IVF/ET. J Assist Reprod Genet 14: 603-606
10. Cowchok FS. Reece EA. Balaban D. Branch DW. Plouffe L (1992) Repeated fetal losses associated with antiphospholipid antibodies: A collaborative randomised trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol 166:1318-1323
11. Di Simone N, Ferrazzani S, Castellani R (1997) Heparin and low-dose aspirin restore placental humen chorionic gonadotrophin secretion abolished by antiphospholipid antibody-containing sera. Hum Reprod 12: 2061-2065
12. Di Simone, Caliandro D, Castellani R, et al. (1999) Low molecular weight heparin restores in-vitro trophoblast invasiveness and differentiation in presence of immunoglobulin G fractions obtained form patients with antiphospholipid syndrome. Hum Reprod 14: 489-495
13. Eldar-Geva T. Wood C. Lolatgis N. et al. (1999) Cumulative pregnancy and live birth rates in women with antiphospholipid antibodies undergoing assisted reproduction. Human Repro 14: 1461-1466
14. El-Roeiy A, Myers SA, Gleicher N (1990) The prevalence of autoantibodies and lupus anticoagulant in healthy pregnant women. Obstet Gynecol 75: 390-396
15. Empson M. Lassere M. Craig JC. Scott JR (2002) Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials. Obstet-Gynecol 99: 135-144
16. Farquharson RG, Quenby S, Greaves M (2002) Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstet Gynecol 100:408-413
17. Fausett MB, Branch DW (2002) Autoimmune causes of recurrent pregnancy loss. Infertility Reproductive medicine. Clinics of North America 13: 159-182
18. Fausett MB, Branch DW (2000) Autoimmunity and pregnancy loss. Semin Reprod Med 18: 379-392
19. Fiedler K, Ludwig M (2003) The use of clomiphene citrate in in vitro fertilization (IVF) and IVF intracytoplasmic sperm injection cycles. Fertil Steril 50: 1521-1523
20. Franklin RD, Kutteh WH (2003) Effects of unfractionated and low molecular weight heparin on antiphospholipid antibody binding in vitro. Obstet Gynecol 101: 455-462
21. Fukui A, Fuji S, Yamaguchi E et al. (1999) Natural killer cell subpopulations and cytotoxicity for infertile patients undergoning in vitro fertilization. AJRI 41: 413
22. Geva E, Amit A, Lerner-Geva L, et al. (1998) Prevention of early pregnancy loss in autoantibody seropositive women. Lancet 351: 34/35.
23. Geva E, Amit A, Lerner-Geva L, Azem. F, Yovel I, Lessin JB (1995) Autoimmune disorders: another possible cause for in-vitro fertilization and embryo transfer failure. Hum Reprod 10: 2560-2563
24. Gharavi AE, Harris EN, Asherson RA, et al. (1987) Anticardiolipin antibodies: Isotype distribution and phospholipid specificity. Ann Rheum Dis 46: 1-6.
25. Ghazeeri GS, Kutteh WH (2002) Autoimmunity and assited reproduction. Infertility and reproductive medicine. Clinics of North America 13: 183-201
26. Ghazeeri GS. Kutteh WH (2001) Autoimmune factors in reproductive failure. Curr Op Obstet Gynecol 13: 287-291
27. Gleicher N, El Roeity A, Confino E, Friberg J (1989) Reproductive failure because of autoantibodies: unexplained infertility and pregnancy wastage. Am J Obstet Gynecol 160: 1307-1385
28. Gleicher N, Vidali A, Karande V (2002) The immunological "War of the Roses:" disagreements amongst reproductive immunologists. Human Reprod 17: 539-542
29. Greaves M (1999) Antiphospholipid antbodies and thrombosis. Lancet 353: 1348-1353
30. Harris E (1990) The second anticardiolipin standardization workshop/the Kingston antiphospholipid antibody study group. Am J Clin Pathol 94: 476-484
31. Harris EN, Spinnato JA (1991) Should anticardiolipin tests be performed in otherwise healthy pregnant women? AM J Obstet Gynecol 165: 1272-1277
32. Heilmann L, Rath W, von Tempelhoff GF, et al. (2002) Niedermolekulare Heparine in der Schwangerschaft. Dt Ärzteblatt 7: A424-A430
33. Hill J, Scott R (2000) Immunological tests and and IVF: "please enough already." Fertil Steril 74: 439-442
34. Hornstein M, Davis O, Massey J, Paulson R, Collins J (2000) Antiphospholipid antibodies and in vitro fertilization success: a meta-analysis. Fertil Steril 73: 330-333
35. Huong du LT, Wechsler B, Vauthier-Brouzes D, Duhaut P, Costedoat N, Lefebvre G, Piette JC (2002) Importance of planning ovulation induction therapy in systemic lupus erythematosus and antiphospholipid syndrome: a single centre retrospective study of 21 cases and 114 cycles. Semin Arthritis Rheum 32: 174-188
36. Kaider AS, Kaider BD, Janowicz PB, Rouseev RG (1999) Immunodiagnostic evaluation in women with reproductive failure. Am J Reprod Immunol 42: 335-346
37. Katsuragawa H, Rote NS, Inoue T, Narukawa S, Kanzaki H, Mori T (1995) Monoclonal antiphosphatidylserine antibody reactivity against human first-trimeste placental trophoblast; Am J Obstet Gynecol 177: 1592-1597
38. Kimber SJ (2000) Molecular interactions at the maternal-embryonic interface during the early phase of implantation. Seminars in Reprod Med 18: 237-253
39. Kirn-Safran CB, Carson DD (1999) Dynamics of uterine glycoconjugate expression and function. Seminars in reproductive endocrinology 17: 217-227
40. Krause MM, Homuth V, Schmider A, et al. (2001) Genetische Grundlagen der schwangerschaftsinduzierten Hypertonie. Gynäkologe 6: 503-509
41. Krüssel JS, Polan ML, Simón C (2002) Cytokine and growth factor network in human endometrium. Infertility Reproductive medicine. Clinics of North America 13: 97-112
42. Künzel W, Lang U, Diedrich K, et al. (2001) Intrauterine Wachstumsretadierung. Aktueller Stand der Forschung. Gynäkologie 9: 783-792
43. Kutteh WH, Rote NS, Silver R (1999) Antiphospholipid antibodies and reproduction: the antiphospholipid antibody syndrome. Am J Reprod Immunol 41: 133-152
44. Kutteh WH, Yetman DL, Chantilis SJ, Crain J (1997) Effect of antiphospholipid antibodies in women undergoing in-vitro fertilization: role of heparin and aspirin. Hum Reprod 12: 1171-1175
45. Kutteh WH (1996) Antiphospholipid antibody-associated recurrent pregnancy loss: Treatment with heparin and low dose aspirin is superior to low dose aspirin. Am J Obstet Gynecol 174: 1584-1589
46. Kwak JY, Gilman-Sachs A, Meaman KD, et al. (1992) Reproductive outcome in women with recurrent spontaneous abortions of alloimmune and autoimmune cuses: Preconception versus postconseption treatment. AM J Obstet Gynecol 166: 1787-1795; discussion 1795-1788
47. Lockwood QJ, Krikun G, Schatz F (1999) The decidua regulates hemostasis in human endometrium. Semin Reprod Endocrino 17: 45-51
48. Mardesic T, Ulcova-Gallova Z, Huttelova R. et al. (2000) The influence of different types of antibodies on in vitro fertilization results. Am J Reprod Immunol 43: 1-5
49. Matzner W, Chong P, Xu g, et al. (1994) Characterization of antiphospholipid antibodies in women with recurrent spontaneous abortions. J Reprod Med 39: 27-30
50. Mor G (2002) Immunology of Implantation. Infertility Reproductive medicine. Clinics of North America 13: 113-128
51. Nikas G (2000) Endometrial Receptivity: Changes in cell-surface morphology. Seminars in reproductive medicine 18: 229-235
52. Ober C, Karrison T, Harlow L, et al. (1993) Autoantibodies and pregnancy history in a healthy population. Am J Obstet Gynecol 169: 143-147
53. Qamar T, Levy RA, Sammaritano L, et al. (2003) Characteristics of high-titer IgG antiphospholipid antibody in systemic lupus erythematosus patients with and without fetal death. Arthritis Rheum 33: 501-504
54. Raghupathy R (2001) Pregnancy: success und failure within the Th1/Th2/ Th3 paraddigm. Semin Immunol 13: 219-227
55. Rai R, Cohen H, Davey M, Regan L (1997) Randomised controlled trial of aspirin and aspirin plus heparin in women with recurrent miscarriage associated with antiphospholipid antibodies. BMJ 314: 253-257
56. Rote NS, Dostal-Johnson D, Branch DW (1990) Antiphospholipid antibodies and recurrent pregnancy loss: Correlation between the activated partial thromboplastin time and antibodies against phosphatidylserine and cardiolipin. AM J Obstet Gynecol 163: 575-584
57. Ruiz JE, Cubillos J, Mendoza JC, et al. (1995) Autoantibodies to phospholipids and nuclear antigens in non-pregnant and pregnant Colombian women with recurrent spontaneous abortions. J Reprod Immunol 28: 41-51
58. Scientific Advisory Committee Opinion Paper of the Royal College, October 2003
59. Sher G, Fisch JD, Maasarani G, et al. (2000) Antibodies to phosphatidylehanolamine and phosphatidylserine are associated with increased natural killer cell activity in nonmale factor infertilitty patients. Hum Reprod 15: 1932-1936
60. Sher G, Feinman M, Zouves C (1994) High fecundity rates following in-vitro fertilization and embryo transfer in seropositive women treated with heparin and aspirin. Hum Reprod 9: 2278-2283
61. Sher G, Fisch JD, Maassarani G. et al. (2000) Antibodies to Phosphtidylethanolamine and phosphtidylserine are associated with increased natural killer cells activity in non-male factor infertility patients. Hum Reprod 15: 1932-1936
62. Starzyk KA, Pijenborg R, Salfin C (1999) Decidual and vascular pathophysiolgy in pregnancy comprimise. Seminars in reproductive endocrinology 17: 63-72
63. Stephenson MD, Ensom MHH (2002) The role of immuntherapy in reproductiv failure. Infertility Reproductive medicine. Clinics of North America 13: 203-220
64. 2-glyco-protein-1 are associated with in vitro fertilization implantation failure as well as recurrent miscarriage: results of a prevalence study. Fertil Steril 70: 938-944
65. Stern C, Chamley L, Norris H, Hale L, Baker HWG (2003) A randomised, double-blind, placebo-controlled trial of heparin and aspirin for women with in vitro fertilization implantation failure and antiphospholipid or antinuclear antibodies. Fertil Steril 80: 376-383
66. Taylor RN, Hornung D, Mueller MD, et al. (2002) Immunology of Endometriosis. Infertility Reproductive medicine. Clinics of North America 13: 145-157
67. Viard JP, Amoura Z, Bach JF (1992) Association of anti-beta 2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus. Am J med 93: 181-186
68. Vince GS, Christmas SE, Johnson PM (2002) Understanding cellular and humoral immunitiy. Infertility Reproductive medicine. Clinics of North America 13: 1- 17
69. Ware Branch D, Hatasaka HH (1998) Antiphospholipid antibodies: fact ore fallacy. Lupus 7(Supp 2): 90-94
70. Willeke A, Gerdsen F, Bauersach RM, et al. (2002) Rationelle Thrombophiliediagnostik. Dt Ärzteblatt 31-32: A2111-A2118
71. Wilson WA. Gharavi AE. Koike T. et al. (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid, syndrome. Arthritis Rheum 42: 1309-1311
72. Würfel W, Fiedler K, Krüsmann G, et al (2DOl) Verbesserung der Behandlugnsergebnisse durch LeukoNorm Cytochemia® bei Patientinnen mit mehrfachen, frustranen IVF- oder ICSI-Behandlungszyklen. Zentralbl Gynäkol 123: 361-365
73. Würfel W (2003) Immuntherapie bei ART Versagern. Reproduktionsmedizin 19(2): 108 ff
74. Würfel W (2003) Immuntherapie bei wiederholten Aborten und ART-Versagern. medifact-publishing
75. Zygmunt M, Münstedt K, Lang U (2001) Die Rolleder Vaskulo- und Angiogenese in der embryonalen und fetalen Entwicklung. Eine kurze Übersicht. Gynäkologe 9: 812-819
76. Ghazeeri GS, Kutteh WH (2001) Autoimmune factors in reproductive failure. Curr Op Obstet Gynecol 13: 287-291